Related Experiment Video
Updated: Jul 15, 2025

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks
Published on: June 26, 2020
What is the Path Forward to Treat Hepatitis Delta Virus?: Old Treatments and New Options
1University of Paris-Cité, Hôpital Beaujon, Service d'hépatologie AP-HP & INSERM UMR1149, Clichy, France.
Abstract:
HDV use the cell enzymes for its own replication, and the HBsAg as an envelope. There is an urgent need to develop new drugs for chronic hepatitis D (CHD). Pegylated interferon alpha (PEG-IFNα) (direct-antiviral and immune modulator) has been used and recommended by scientific guidelines, although not approved, with moderate efficacy and poor tolerability. There are several drugs in development which target the host: bulevirtide (BLV), lonafarnib (LNF), nucleic acid polymer, and others.
More Related Videos
Related Concept Videos
Retrovirus Life Cycles
Venous Thrombosis III: Interprofessional Care
Viruses with RNA Genomes
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
Chronic Pancreatitis II: Collaborative Care
Assessment:
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...

